USE OF NON-PEPTIDE NK1 ANTAGONISTS IN A PREDETERMINED DOSE FOR THE TREATMENT OF CANCER

• 收藏
• 分享

专利权人:

Servicio Andaluz de Salud

发明人:

SALINAS MARTIN, Manuel Vicente

申请号：

EP14873139

公开号：

EP3100729A4

申请日:

2014.12.26

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

The invention relates to the use of the non-peptide NK1 receptor antagonist, preferably Aprepitant, for treating cancer in predetermined doses. The present invention also relates to pharmaceutical compositions that include said agents, alone or in combination with at least one other active substance, for treating cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/